https://t.co/icG9l7vko4 https://t.co/Eo6uyaRWbm https://t.co/KH0E3Jncw5
High-throughput virtual screening of phenylpyrimidine derivatives as selective JAK3 antagonists using computational methods.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Dec 2022 – Feb 2024Where it's discussed
-
X / Twitter2 posts
-
YouTube2 videos
AI synopsis
What people are saying
Several posts, including this one, highlight recognition of the publication, such as celebrating its citation and linking it to other significant work, with phrases like 'Delighted to have received a first citation' and references to related publications, illustrating genuine appreciation and interest in the research's academic impact.
The discussion shows positive acknowledgment of the publication's significance, especially with the phrase 'Delighted to have received a first citation,' indicating support and recognition.
The mention of the citation and the connection to another author's work demonstrate a high level of curiosity and appreciation for the research's relevance.
The post reflects moderate engagement, sharing specific details like DOI numbers and referencing related studies, indicating an active interest but not deep analysis.
While positive, the discussion primarily celebrates recognition rather than outlining broad implications or transformative potential of the research.
Abstract in brief
- This research used computational methods, including pharmacophore modeling, 3DQSAR, and molecular docking, to identify phenylpyrimidine derivatives that can selectively inhibit JAK3, an enzyme involved in rheumatoid arthritis.
- The study validated potential inhibitors by analyzing their pharmacokinetics, stability through molecular dynamics, and binding affinity, ensuring they effectively target JAK3 with minimal adverse effects.
- Overall, this approach provides a promising pathway for designing new drugs for rheumatoid arthritis, utilizing advanced computer simulations to identify and optimize potential therapeutic compounds.
Top posts
Most liked on X and BlueskyDelighted to have received a first citation for the year 2024 for our article (DOI: 10.1080/07391102.2023.2240413) in the excellent work presented by Dr. Anita Ioana Visan (DOI: 10.3390/life14020233) in the journal Life.
All mentions
Molecular Docking with AutoDock for JAK3 Inhibitor Development
This video demonstrates the use of AutoDock and other computational tools to develop novel JAK3 inhibitors, targeting autoimmune diseases and cancer, through molecular docking, dynamics simulations, and free energy…
Computational Screening for JAK3 Inhibitors in Rheumatoid Arthritis Treatment
This research uses computational methods, including pharmacophore modeling, 3DQSAR, and molecular docking, to identify phenylpyrimidine derivatives that can selectively inhibit JAK3, an enzyme involved in rheumatoid…
https://t.co/icG9l7vko4 https://t.co/Eo6uyaRWbm https://t.co/KH0E3Jncw5
Delighted to have received a first citation for the year 2024 for our article (DOI: 10.1080/07391102.2023.2240413) in the excellent work presented by Dr. Anita Ioana Visan (DOI: 10.3390/life14020233) in the journal Life.
AF